LLY

Eli Lilly and Company · BIVA:LLY

26,778.00 MXN989.73 +3.84%

Eli Lilly and Company (BIVA:LLY) last traded at 26,778.00 MXN, up 3.84% on the day. Over the past year the stock is up 78.82%. Its 52-week range is 14,891.75 to 26,913.16. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open25,845.89

Day range25,845.89 – 26,913.16

52-week range14,891.75 – 26,913.16

Volume105

Average volume (10 days)403

Market cap (USD)1.33 T

P/E48.64

EPS (TTM) (USD)30.44

Dividend yield0.47%

Beta (1 year)−0.0688

Revenue (TTM) (USD)86.46 B

Employees50.00 K

Performance

+9.59%1 week

+25.09%1 month

+33.58%3 months

+79.82%6 months

+38.42%Year to date

+78.82%1 year

Technical rating

Strong buy

Daily summary of 11 oscillators and 15 moving averages. See every indicator

Analysts’ target

27,409.70 MXN

The average 1-year price target, +2.36% from the last price. See the forecast

Latest headlines

Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
Healthcare sector rallies in October amid rotation away from technology stocksSeeking Alpha · 31 Oct 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Elon Musk Says Eli Lilly Has ‘Some Banger Drugs Coming Out’ After CEO Dave Ricks Bets Against Vinod Khosla's Big Biotech SkepticismBenzinga · 31 Oct 2026
Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Stocktwits · 31 Oct 2026
Eli Lilly Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
UBS maintains Eli Lilly at Buy, raises price target to $1625 from $1425TradingView · 31 Oct 2026
What Eli Lilly and Company (LLY) Said on Its Q3 Earnings CallMarketBeat · 30 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.